TuHURA Biosciences (HURA) Net Equity Issued and Repurchased (2013 - 2026)

TuHURA Biosciences' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $24.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $18.3 million, up 266.07% from the prior year.
• Net Equity Issued and Repurchased climbed to $7.5 million in Q1 2026 per HURA's latest filing, from $6.2 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $10.5 million in Q1 2024 and bottomed at $105000.0 in Q4 2023.
• The 4-year median for Net Equity Issued and Repurchased is $6.2 million (2025), against an average of $5.9 million.
• Biggest YoY gain for Net Equity Issued and Repurchased was 23.95% in 2025; the steepest drop was 23.95% in 2025.
• Year by year, Net Equity Issued and Repurchased stood at $105000.0 in 2023, then surged by 4661.9% to $5.0 million in 2024, then rose by 23.82% to $6.2 million in 2025, then advanced by 21.14% to $7.5 million in 2026.
• Per Business Quant, the three latest HURA Net Equity Issued and Repurchased figures stand at $7.5 million (Q1 2026), $6.2 million (Q4 2025), and $6.2 million (Q3 2025).